PHLPP1 and Parkinson disease: This modulation of neuroinflammation by PHLPP1 is likely a contributing factor to the protection against dopaminergic neuronal death, highlighting its potential to become a therapeutic target in the management of PD and its associated neuroinflammatory processes.